Taken together, these results suggest that erinacine A treatment upregulated the death receptor molecules, such as Fas, FasL, and TNFR through JNK MAPK/p300/NFκB pathway-mediated histone H3K9K14ac modification, in order to induce CRC apoptosis. The gene discussed is FAS; the disease is colorectal carcinoma.